NYSE:ETWO
NYSE:ETWOSoftware

Will Improved Q1 Results and 2026 Guidance Change E2open’s (ETWO) Narrative?

E2open Parent Holdings, Inc. recently reported its first quarter 2025 results, showing revenue of US$152.61 million and a significant reduction in net loss to US$14.13 million compared to the prior year. Alongside improved financial performance, the company affirmed its full-year 2026 revenue guidance, providing stakeholders with greater visibility and confidence in its operational outlook. We'll explore how the company's continuation of annual guidance, despite current subscription revenue...
NasdaqGM:APGE
NasdaqGM:APGEBiotechs

Did Positive Phase 2 APG777 Results Just Shift Apogee Therapeutics' (APGE) Investment Narrative?

Earlier this month, Apogee Therapeutics announced positive 16-week results from Part A of its Phase 2 APEX trial evaluating APG777 in adults with moderate-to-severe atopic dermatitis, with the therapy meeting its primary efficacy endpoint and showing rapid itch relief and robust lesion reduction compared to placebo. Importantly, efficacy results for APG777 compared favorably across endpoints with existing standard of care biologics, while also maintaining a favorable safety profile and a low...